Pharmaceutical software developer Simulations Plus had a drop in its net income for the third quarter when compared with a year ago. For the quarter ending May 31, the Lancaster-based firm reported net income of $569,133 or $0.03 per diluted share, on revenues of $2.7 million. For the same period a year ago, net income was $752,661, or $0.04 per diluted share, on revenues of $3 million.. For the nine month period, Simulations Plus reported net income of $1.2 million, or $0.07 per diluted share, on revenues of $7.3 million. For the same period a year ago, the company had net income of $1.6 million, or $0.09 per diluted share, on revenues of $7.1 million. Simulations expects to complete one or two acquisitions during the fiscal year, Chairman and CEO Walt Woltosz said. Mark R. Madler
